Nipro Corporation, together with its subsidiaries, is engaged in the medical equipment, pharmaceuticals, and glass businesses. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, dialysis products, advanced products, and diabetes products. Its Pharmaceutical-Related Business segment provides generic drugs, injectable drugs; oral drugs; injection kit products; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass for lighting purposes. Nipro Corporation is also involved in the rental of real estate properties. It operates primarily in Japan, Europe, rest of Asia, and the United States of America. The company was founded in 1954 and is headquartered in Osaka, Japan.
nipro corp (8086:Tokyo Stock Exchange)
Phone: 81 6 6372 2331
Fax: 81 6 6375 0669www.nipro.co.jp
|Baxter International Inc||$76.59 USD||-0.16|
|Fresenius Medical Care AG & Co KGaA||€49.85 EUR||+0.21|
|JMS Co Ltd||¥298.00 JPY||+3.00|
|Nikkiso Co Ltd||¥1,174 JPY||+1.00|
|NxStage Medical Inc||$13.77 USD||+0.05|
|View Industry Companies|
Sponsored Financial Commentaries
To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.